Last reviewed · How we verify
NCT04078646: CAROPROT
Influence of Proteins on the Bioavailability of Carotenoids
NA trial testing Intervention with soy protein isolate in Absorption; Chemicals in 24 participants. Completed in 30 June 2021.
30 June 2021
Quick facts
| Lead sponsor | Luxembourg Institute of Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 24 |
| Start date | 11 October 2019 |
| Primary completion | 30 June 2021 |
| Estimated completion | 30 June 2021 |
| Sites | 1 location across Luxembourg |
Drugs / interventions tested
- Intervention with soy protein isolate
- Intervention with whey protein
- Intervention without protein addition
Conditions studied
- Absorption; Chemicals — all drugs for Absorption; Chemicals →
- Healthy Diet — all drugs for Healthy Diet →
- Metabolism — all drugs for Metabolism →
Sponsor
Luxembourg Institute of Health
Who can join
Adults 20 to 50, male only, with Absorption; Chemicals or Healthy Diet. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A postprandial intervention study is conducted on healthy male subjects to evaluate whether the addition of proteins (why protein isolate, soy protein) can help to increase the bioavailability of carotenoids from a tomato/carrot beverage.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Whey- and Soy Protein Isolates Added to a Carrot-Tomato Juice Alter Carotenoid Bioavailability in Healthy Adults.
Iddir M, Pittois D, Guignard C, Weber B, et al · · 2021 · cited 10× · PMID 34829619 · DOI 10.3390/antiox10111748
Verify or expand the search:
- PubMed search for NCT04078646
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Luxembourg Institute of Health trials
Trials by the same sponsor.
- NCT07500259 — Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and P · not yet recruiting
- NCT06235684 — Clinnova-RD: A Prospective Cohort Study of Patients With Rheumatoid Diseases · not yet recruiting
- NCT07156994 — Development of Voice Biomarkers of Frequent COVID-19 and Long Covid-related Symptoms Based on Data From Users of the Lon · not yet recruiting
- NCT06816147 — HealthyW8_60+ Pilot · NA · recruiting
- NCT06384872 — Effect of Shoe Cushioning Position and Properties on Running-related Injury Risk · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04078646 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Luxembourg Institute of Health
- Last refreshed: 23 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04078646.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing